Intuitive Surgical stock has results due October 20, 2026

Published on 10/15/2026 at 15:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 18.40 percent to USD 2.89 billion. Intuitive Surgical stock costs EUR 378.58 on October 15, 2026 at Lang & Schwarz.

Results and market valuation

Intuitive Surgical's third-quarter 2026 results are scheduled for October 20, 2026.
Second-quarter revenue reached USD 2.89 billion, up 18.40 percent year over year.
Intuitive Surgical stock costs EUR 378.58 at 3:02 p.m. CEST at Lang & Schwarz on October 15, 2026.
Market capitalization stood at USD 148.5 billion as of October 14, 2026.

Pop-Art-Comic zeigt Operationsroboter mit mehreren Armen und Chirurgen an der Konsole — Farbenfrohe Pop-Art-Comic-Szene aus dem Operationssaal illustriert Intuitive Surgical Inc. (US46120E6023) mit dynamischer Chirurgie-Roboter-Darstellung, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) has its third-quarter 2026 results scheduled for October 20, 2026, according to Intuitive Surgical. The date gives investors a fixed event around which to assess the current valuation. The stock was trading at EUR 378.58 at Lang & Schwarz on October 15, 2026 at 3:02 p.m. CEST.

Revenue growth remains substantial

Intuitive Surgical generated USD 2.89 billion in revenue in the second quarter of 2026, up 18.40 percent from USD 2.44 billion in the second quarter of 2025, according to Markets Insider. Net profit reached USD 818.1 million in the second quarter of 2026, compared with USD 658.4 million a year earlier. The comparison keeps the upcoming report focused on whether procedure growth and recurring instrument sales can sustain the companys elevated valuation.

Price position and trading frame

As of October 14, 2026, Intuitive Surgical had a USD 328.57 to USD 603.88 52-week range. The latest finance quotation listed a USD 148.5 billion market capitalization, while volume was 1,914,576 shares against an average of 2,822,687 shares. Those figures place the company among the largest medical-technology names, but the share price remains well below its 52-week high.

Valuation and upcoming date

The price-to-earnings ratio was 47.81 as of October 14, 2026. Intuitive Surgical does not currently carry a dividend yield in the quoted market data. The companys investor-relations calendar identifies October 20, 2026, as the date for the third-quarter earnings conference call, making the report the next scheduled company-specific event.

Comparison with peers

Intuitive Surgical (Nasdaq, USD): P/E 47.81, market capitalization USD 148.5 billion
Medtronic (NYSE, USD): plus 1.31 percent, P/E 23.21, market capitalization USD 120.5 billion
Stryker (NYSE, USD): minus 0.33 percent, P/E 29.18, market capitalization USD 108.0 billion

What the next report will test

The October 20 release will provide the next dated operating checkpoint after the second-quarter revenue increase. For investors, the key comparison is whether the 18.40 percent year-over-year revenue gain is accompanied by similarly durable earnings growth. The current market value and P/E ratio leave little room for an abrupt weakening in procedure demand.

Stock price in euros

Intuitive Surgical stock was trading at EUR 378.58 at Lang & Schwarz on October 15, 2026 at 3:02 p.m. CEST. The quote remains the central euro reference for investors in Germany ahead of the next results date.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.